Morbidity and maternal and infant outcomes of hypertensive disorder in pregnancy in China in 2018
The Journal of Clinical Hypertension Apr 06, 2021
Lyu X, Zhang W, Zhang J, et al. - In order to determine the morbidity and maternal and infant outcomes with respect to the hypertensive disorder in pregnancy in China in 2018, researchers herein assessed retrospectively collected clinical data of 38,590 cases from 161 hospitals. Overall national average morbidity was 4.74%, and the ratio of gestational hypertension was 29.17%, preeclampsia was 55.02%, eclampsia was 0.66%, chronic hypertension was 6.53%, and chronic hypertension with superimposed preeclampsia was 8.62%. Analysis revealed the overall maternal mortality of 0.61/100,000, and the case fatality of 0.13%. Data revealed overall perinatal mortality of 3.59% (81.09% for stillbirths; 18.91% for neonatal deaths). All regions of the country exhibited perinatal mortality < 10% for delivery at 32 weeks of gestation. Overall regions in China varied in morbidity, with the lowest in Southwest and the highest in North China. The large‐scale development of standardized maternal health care has led to the low maternal mortality in China. For better neonatal survival rates, they emphasize prolonging gestation to 32 weeks as often as possible in severe hypertensive disorder patients.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries